ZyVersa units weight problems as focus for brand spanking new drug IC 100 By Investing.com
WESTON, Fla. - ZyVersa Therapeutics, Inc. (NASDAQ:ZVSA), a biopharmaceutical firm specializing within…
Scotiabank sees ‘deep worth’ in Sage Therapeutics inventory regardless of research setback By Investing.com
On Wednesday, Scotiabank adjusted its outlook on Sage Therapeutics (NASDAQ:SAGE), decreasing the…
First Residents BancShares Declares Dividends By Investing.com
RALEIGH, N.C., July 25, 2024 /PRNewswire/ -- The Board of Administrators of…
JPMorgan ups Matador Assets shares goal amid larger manufacturing and FCF estimates By Investing.com
On Thursday, JPMorgan up to date its outlook on Matador Assets Firm…
Lifeway Meals insider sells over $179k in firm inventory By Investing.com
In a current transaction on July 24, a member of the ten%…
Terra Balcanica Closes Choice Settlement for Saskatchewan Uranium Belongings By Investing.com
Vancouver, British Columbia, July 24, 2024 (GLOBE NEWSWIRE) -- Terra Balcanica Sources…
Vertex insider sells $56.7 million in firm inventory By Investing.com
In a big transfer inside Vertex (NASDAQ:), Inc. (NASDAQ:VERX), an insider has…
aTYR Pharma director Paul Schimmel buys $184k in firm shares By Investing.com
In a current sequence of transactions, Paul Schimmel, a director at aTYR…
Moelis & Firm reviews sturdy development in Q2 2024 earnings By Investing.com
NEW YORK - Moelis & Firm (NYSE:), a worldwide unbiased funding financial…
SONN hits 52-week low, buying and selling at 0.82 USD By Investing.com
SONN, the ticker image for Sonnet BioTherapeutics Holdings (NASDAQ:), Inc., has just…
